Pten (phosphatase and tensin homologue gene) haploinsufficiency promotes insulin hypersensitivity

Diabetologia. 2007 Feb;50(2):395-403. doi: 10.1007/s00125-006-0531-x. Epub 2006 Dec 29.

Abstract

Aims/hypothesis: Insulin controls glucose metabolism via multiple signalling pathways, including the phosphatidylinositol 3-kinase (PI3K) pathway in muscle and adipose tissue. The protein/lipid phosphatase Pten (phosphatase and tensin homologue deleted on chromosome 10) attenuates PI3K signalling by dephosphorylating the phosphatidylinositol 3,4,5-trisphosphate generated by PI3K. The current study was aimed at investigating the effect of haploinsufficiency for Pten on insulin-stimulated glucose uptake.

Materials and methods: Insulin sensitivity in Pten heterozygous (Pten(+/-)) mice was investigated in i.p. insulin challenge and glucose tolerance tests. Glucose uptake was monitored in vitro in primary cultures of myocytes from Pten(+/-) mice, and in vivo by positron emission tomography. The phosphorylation status of protein kinase B (PKB/Akt), a downstream signalling protein in the PI3K pathway, and glycogen synthase kinase 3beta (GSK3beta), a substrate of PKB/Akt, was determined by western immunoblotting.

Results: Following i.p. insulin challenge, blood glucose levels in Pten(+/-) mice remained depressed for up to 120 min, whereas glucose levels in wild-type mice began to recover after approximately 30 min. After glucose challenge, blood glucose returned to normal about twice as rapidly in Pten(+/-) mice. Enhanced glucose uptake was observed both in Pten(+/-) myocytes and in skeletal muscle of Pten(+/-) mice by PET. PKB and GSK3beta phosphorylation was enhanced and prolonged in Pten(+/-) myocytes.

Conclusions/interpretation: Pten is a key negative regulator of insulin-stimulated glucose uptake in vitro and in vivo. The partial reduction of Pten due to Pten haploinsufficiency is enough to elicit enhanced insulin sensitivity and glucose tolerance in Pten(+/-) mice.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Glucose / drug effects
  • Blood Glucose / metabolism
  • Crosses, Genetic
  • Deoxyglucose / metabolism
  • Diabetes Mellitus, Type 2 / genetics
  • Fluorodeoxyglucose F18
  • Genetic Carrier Screening
  • Glucose / pharmacology
  • Glucose Tolerance Test
  • Glucose Transporter Type 1 / metabolism
  • Glucose Transporter Type 4 / metabolism
  • Insulin / blood
  • Insulin / pharmacology*
  • Insulin-Secreting Cells / metabolism
  • Islets of Langerhans / drug effects
  • Islets of Langerhans / metabolism
  • Mice
  • PTEN Phosphohydrolase / deficiency
  • PTEN Phosphohydrolase / genetics*
  • PTEN Phosphohydrolase / metabolism
  • Phosphatidylinositol 3-Kinases / metabolism
  • Positron-Emission Tomography

Substances

  • Blood Glucose
  • Glucose Transporter Type 1
  • Glucose Transporter Type 4
  • Insulin
  • Slc2a1 protein, mouse
  • Slc2a4 protein, mouse
  • Fluorodeoxyglucose F18
  • Deoxyglucose
  • Phosphatidylinositol 3-Kinases
  • PTEN Phosphohydrolase
  • Glucose